Nathaniel Calloway - Jan 9, 2024 Form 4 Insider Report for LIFECORE BIOMEDICAL, INC. \DE\ (LFCR)

Role
Director
Signature
/s/ Rebecca Hilt, Attorney-In-Fact for Nathaniel Calloway
Stock symbol
LFCR
Transactions as of
Jan 9, 2024
Transactions value $
$0
Form type
4
Date filed
1/10/2024, 07:14 PM
Previous filing
Jun 5, 2023
Next filing
Feb 2, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LFCR Common Stock Options Exercise +5.91K +32.48% 24.1K Jan 9, 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LFCR Restricted Stock Unit Options Exercise $0 -5.91K -100% $0.00* 0 Jan 9, 2024 Common Stock 5.91K Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The restricted stock units convert into common stock of Lifecore Biomedical, Inc. on a 1 for 1 basis.
F2 The restricted stock units vested on January 9, 2024.